These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunization Policy and the Importance of Sustainable Vaccine Pricing. Meissner HC JAMA; 2016 Mar; 315(10):981-2. PubMed ID: 26857277 [No Abstract] [Full Text] [Related]
4. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737 [TBL] [Abstract][Full Text] [Related]
5. Costs of vaccine programs across 94 low- and middle-income countries. Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184 [TBL] [Abstract][Full Text] [Related]
6. Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses. Andrus JK; Walker DG Vaccine; 2015 May; 33 Suppl 1():A2-3. PubMed ID: 25919161 [No Abstract] [Full Text] [Related]
7. Economic aspects of vaccines and immunizations. Hinman AR C R Acad Sci III; 1999 Nov; 322(11):989-94. PubMed ID: 10646095 [TBL] [Abstract][Full Text] [Related]
8. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries? Brenzel L Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183 [TBL] [Abstract][Full Text] [Related]
9. Examining the cost of delivering routine immunization in Honduras. Janusz CB; Castañeda-Orjuela C; Molina Aguilera IB; Felix Garcia AG; Mendoza L; Díaz IY; Resch SC Vaccine; 2015 May; 33 Suppl 1():A53-9. PubMed ID: 25919175 [TBL] [Abstract][Full Text] [Related]
10. Health economic research on vaccinations and immunisation practices--an introductory primer. Szucs TD Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578 [TBL] [Abstract][Full Text] [Related]
11. [Cost of tetanus toxoid injection using a jet-injector (Imule) in collective immunization in Senegal: comparison with injection using a syringe and resterilizable needle]. Schlumberger M; Châtelet IP; Lafarge H; Genêt A; Gaye AB; Monnereau A; Sanou C; Diawara L; Gueye Y; Lang J Sante; 1999; 9(5):319-26. PubMed ID: 10657777 [TBL] [Abstract][Full Text] [Related]
12. Perspectives on the development and use of economic evidence for immunization decision-making in a developing country. Molina-Aguilera IB Vaccine; 2015 May; 33 Suppl 1():A6-7. PubMed ID: 25919176 [No Abstract] [Full Text] [Related]
14. Analytics for vaccine economics and pricing: insights and observations. Robbins MJ; Jacobson SH Expert Rev Vaccines; 2015 Apr; 14(4):605-16. PubMed ID: 25435003 [TBL] [Abstract][Full Text] [Related]
15. Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania. Mvundura M; Lorenson K; Chweya A; Kigadye R; Bartholomew K; Makame M; Lennon TP; Mwangi S; Kirika L; Kamau P; Otieno A; Murunga P; Omurwa T; Dafrossa L; Kristensen D Vaccine; 2015 May; 33(23):2697-703. PubMed ID: 25865467 [TBL] [Abstract][Full Text] [Related]
16. How important are airfreight rates and vaccine packaging in cost-saving efforts for the Expanded Programme on Immunization? Schreuder B; Arentsen H; Matosse M Bull World Health Organ; 1997; 75(4):315-21. PubMed ID: 9342890 [TBL] [Abstract][Full Text] [Related]